Europa Biosite has announced an agreement to acquire MEDISTA spol. s r.o., expanding into the Czech Republic and strengthening its diagnostics capabilities. The company described the transaction as an acquisition of MEDISTA spol. s r.o. The financial amount of the deal was not disclosed in the sources.
The announcement was reported on 5 November 2026. Europa Biosite framed the move as an expansion into the Czech market and a strengthening of its diagnostics capabilities. No further details on the transaction, including its terms, timing of completion, or the parties' advisers, were provided in the available sources.